'All good news' from Motif Bio's Phase III clinical trial of Iclaprim, says CEO Graham Lumsden
Free Button: Daily News
Free Button: Daily News
Info
Email Video to Friends
Receive Emails for Similar Videos
Repeat and Loop Video
Link to Video
Create Short URL Publish Text About This Video
Share on Facebook, Twitter, and more
See Recommended Videos For You
Description
Graham Lumsden, chief executive of Motif Bio Plc (LON: MTFB, NASDAQ:MTFB) runs Proactive through the successful completion of a phase III clinical trial of their next-generation antibiotic, Iclaprim.The REVIVE-1 global study assessed the drug’s ability to treat patients with acute bacterial skin and skin structure infections (ABSSSI).Tags
iclaprim graham lumsden motif bioShare:
Copied!
Related
Motif Bio on track to move forward with new drug application after Iclaprim success 
The 'end of the marathon' for Motif Bio's Iclaprim 
Amphion Innovations pinning hopes on Polarean Inc after Motif Bio success 
Motif Bio celebrates 'major milestone 'in antibiotic trial' 
Motif Bio gearing up to present at major conference on infectious diseases 
Phase III Iclaprim trial results 'bode very well' for Motif Bio, says Northland Capital's Alexandre 
Motif Bio keen for UK shareholder participation in New York investor meeting 
ImmuPharma’s McCarthy on phase III Lupuzor trials 
'We have absolutely no side effect profile in Lupuzor at all' says ImmuPharma chairman 
'This year will give us the results we've been waiting for', says Faron pharmaceuticals boss 
NeuroEM device could help millions with Alzheimer's; Banner Health looking for trial participants 
Ergomed boss runs Proactive through 'very good results' from Phase II trial for insomnia treatment 
ReNeuron CFO 'pleased' with reformulation of degenerative diseases treatment 
Amryt Pharma's Joe Wiley 'delighted' to soon begin Phase III EB Study 
Dr. Plimack on Combo of Pembrolizumab/Epacodostat in Bladder Cancer 
Adjuvant Therapy for HER2-Driven Breast Cancer 
Nanobiotix approval for liver cancer trials 
Scancell boss 'very excited' about collaboration deal with leading US lung cancer foundation 
Phase III Ibrutinib Findings, Prostate Cancer Congress, and More 
FDA Approval in Myeloma, Priority Review in ALL, and 2017 GU Cancers Symposium Highlights 
Pharmaxis gets A$27M injection from Boehringer Ingelheim 
Dr. Chiara Cremolini on Frontline FOLFOXIRI Plus Bevacizumab in mCRC 
CALGB 80405 Trial Results in Metastatic Colorectal Cancer 
Admedus COO encouraged by initial results from Phase II herpes vaccine trial 
Amryt Pharma 'delighted' to kick off Episalvan trial 
Phase II Trial of Midostaurin in ASM 
Microneedle Patches For Flu Vaccine Found Successful 
Phase 2 Clinical Trial Update 1 
Dr. Finn on the Phase III PALOMA-2 Trial in ER+ Breast Cancer 
Dr. Moore on the NOVA Trial for Ovarian Cancer 
Dr. Marty on Letermovir for CMV after Bone Marrow Transplant 
Summit Therapeutics aiming to 'make a big impact' with new drug Ridinilazole 
Immupharma 'looking forward and planning for success' with Lupuzor 
Clinical Hold Lifted in AML, and Encouraging Phase III Findings in Myeloma, CLL, and Breast Cancer 
ReNeuron making good progress in clinical trial, says CFO 
T-DM1 Plus Pertuzumab in the MARIANNE Trial 
FDA Approval in MZL, Delay in Immunotherapy Combos in NSCLC, and 2017 GI Symposium Highlights 
FDA Approvals in ALL, Ovarian Cancer, Priority Review in CTCL, and sNDA Submitted in RCC 
Lupuzor safety profile 'holding up' - ImmuPharma's Tim McCarthy updates on Phase III study 
Dr. Mirza on Niraparib Plus Bevacizumab Combo in Ovarian Cancer 
Dr. Bauer on Evolution of Phase I Trials 
New Drug Shows Promise for Celiac Patients – Celiac Disease in the News 
Dr. Finn on Significance of Phase III Findings of Lenvatinib in HCC 
[Webinar] Givinostat in Duchenne - April 2017 
Dr. von Minckwitz on the Safety Profile of the APHINITY Trial for HER2+ Breast Cancer 
Dr. Ramalingam on FLAURA Findings in EGFR-Mutant NSCLC 
Dr. Ledermann on Phase III ARIEL3 Results in Ovarian Cancer 
Dr. Montal on Molecular Predictors of Recurrence With Adjuvant Sorafenib in HCC 
[Webinar] Results from Phase I/II HOPE Clinical Trial of CAP-1002 - April 2017 
ASCEND-4: Upfront Ceritinib in ALK-Rearranged NSCLC 
Clinigen now has a “complete global reach”, says chief 
Clinical trial hailed as "game changer" for Alzheimer's 
Amryt Pharma chief looking to “unlock a large market opportunity” 
2015 AACR Annual Meeting Highlights 
New NCI Director, Early Release of Prostate Cancer Data, Disappointing Findings in RCC, and More 
Clinical trial for MS could prove 'immense commercial significance' of Rex Technology, says CEO 
Cop in Ramarley Graham shooting, Richard Haste, to start departmental trial in November, council... 
UW clinical trial holds hope for lung cancer patients 
Successful Early Clinical Trials For New Flu Drug 
Jodi Arias full family impact statements 
Jury hears from lawyers during sentencing phase of Eric Campbell trial 
Single malts' sales will rise in India: Bill Lumsden 
PARP Inhibitors for BRCA-Mutated TNBC 
University of Hawaii Cancer Center: Honoring Clinical Trial Participants 
Destiny Pharma to push ahead with next-generation antibiotic after $15mln IPO 
Mini Slimline DirecTV HD Ka/Ku Satellite Dish 
Immunotherapy for Management of Stage 3B NSCLC 
Patients Call Participating in Clinical Trials at UK "Empowering" 
ReNeuron CFO 'very encouraged' with stroke study results 
[Webinar] Summit's Utrophin Modulation Program - January 2017 
Dr. Trotman on BGB-3111 in Patients With Waldenstrom’s Macroglobulinemia 
Dr. Choueiri on Impact of CABOSUN Results in Renal Cell Carcinoma 
Dimerix Ltd's Kathy Harrison discusses positive outcomes from Phase II clinical trial 
FDA approves treatment for rare brain disease 
[Webinar] Akashi Provides Update on HT-100 - March 2017 Popular Today
Lockdown in Bengaluru: Day 2 
I've been moved by everything going on in the world lately and I finally mustard up recording my first song to completion. It's a call for more love and compassion. Due to it's relation to global warming, police violence, covid, and police violence I felt it fit in politics. 
New EV charging plaza in Delhi 
Emmy Nominations 2020 
Facebook, Google, Apple, Amazon CEOs testify before US House antitrust subcommittee 
Police investigating south county apartment fire that left one dead 
Man arrested after making scene about refusing to wear mask 
Tony Hawk breaks down skateboarding’s legendary spots 
SHOCKING Jeffrey Epstein and Ghislaine Maxwell Documents Released 
Plus d'une centaine de migrants secourus accostent à Lampedusa | AFP 
Railways To Revamp IRCTC Website: Check Out The New Features 
Kyle Kulinski: Previewing The Hellish Future Of MSNBC In The Biden Era 
Mangroves - Restoring the guardian forests 
Dr. Khong on Endocrine Combinations in ER+/HER2- Breast Cancer 
How slow motion works 
Unemployment agency makes progress on delayed benefits, but many Oklahomans still waiting 
Le crabe bleu, bête noire des pêcheurs albanais | AFP 
Riots cases: LG Anil Baijal overturns Delhi cabinet's decision on lawyers' panel 
Maple Leafs Practice - August 3, 2020 
Make America White Again: Eddie Glaude on Trump and What James Baldwin Still Has to Teach Us 
Families mark El Paso Walmart shooting anniversary 
The fight for America's 51st state, explained 
Amazon 2Q Earnings Smash Estimates 
Les 10 images de la semaine (25-31 juillet) | AFP Photo 
5 Rafale Fighter Jets land in India 
Maple Leafs Post Game - August 2, 2020 
AG William Barr Runs Into A Buzz Saw | Tim Black 
Belgium fights COVID-19 surge 
Why scientists are so worried about this glacier 
Byeong Hun An shoots 4-under 66 | Round 3 | WGC-FedEx St. Jude 
Aïd al-Adha : des célébrations marquées par la crise sanitaire | AFP 
PM Modi to address nation on New Education Policy 
Maple Leafs Morning Skate - August 2, 2020 
Saint Louis Zoo's elephant calf has passed away 
Are more parents considering homeschooling kids due to coronavirus? 
Black Kids Crying On Ground, Wrongly Arrested (VIDEO) 
This Breonna Taylor Update Will ENRAGE You! 
The Other Outbreak: False & Misleading Claims 
Protest against privatisation 
Maple Leafs Practice - July 14, 2020 
Wild For Life Journeys - Marine 
CheckMate-9LA: Histology and Frontline Impact 
Meet the First American Marxist: Joseph Weydemeyer 
Education officials respond to Gov. Stitt’s pledge to provide personal protective equipment 
60 ans après son indépendance, le Bénin tente de s'émanciper | AFP 
Supreme Court bars registration of BS-IV vehicles till further orders 
Dude, where's my Stimulus Check? 
Seattle & Portland Activists: Protest Federal and City Police Crackdowns & Keep Focus on BLM Agenda 
Back to school in Georgia brings caution and tears 
Overwatch Summer Games 2020 - NEW Event Skins, Highlight Intros and More! | Hammeh View All Today's Popular Videos